Contributor(s): Author: Joseph F.
Goldberg Author: Carrie L.
Ernst Foreword by: Stephen M.
Stahl Information about new psychotropic drugs, a summary of advances in knowledge about identifiable risk factors for adverse effects, and updated recommendations on viable antidote management strategies -- including novel pharmacotherapies for tardive dyskinesia and newer agents for weight loss -- are among the features of this new, second e.
Contributor(s) | Authorjoseph |
---|---|
Author | Carrie |
Foreword by | Stephen |